Aarti Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

1,169.17

1,176.03

1,234.69

1,016.48

990.71

Operating profit

137.33

124.91

174.78

143.40

225.07

Interest

15.32

15.06

10.84

9.22

13.37

Gross profit

123.40

110.18

166.18

136.71

213.20

EPS (Rs)

8.06

6.80

11.75

9.30

61.29

Other income

1.39

0.33

2.24

2.53

1.50

Stock adjustment

-15.90

-75.06

-25.77

-52.17

-6.66

Raw material

790.99

865.59

824.67

700.12

581.14

Power and fuel

-

-

-

-

-

Employee expenses

40.70

34.74

35.67

33.65

35.24

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

216.05

225.85

225.34

191.48

155.92

Provisions made

-

-

-

-

-

Depreciation

23.53

23.75

23.83

23.56

23.89

Taxation

25.75

23.50

33.50

27.00

46.50

Net profit / loss

74.12

62.93

108.85

86.15

142.81

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

91.94

92.60

92.60

92.60

23.30

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.75

10.62

14.16

14.11

22.72

GPM (%)

10.54

9.37

13.43

13.42

21.49

NPM (%)

6.33

5.35

8.80

8.45

14.39